Ngā hua rapu - Alan D. D’Andrea
- E whakaatu ana i te 1 - 20 hua o te 162
- Haere ki te Whārangi Whai Ake
-
1
The Fanconi road to cancer: Figure 1. mā Alan D. D’Andrea
I whakaputaina 2003Revisão -
2
Susceptibility Pathways in Fanconi's Anemia and Breast Cancer mā Alan D. D’Andrea
I whakaputaina 2010Revisão -
3
Mechanisms of PARP inhibitor sensitivity and resistance mā Alan D. D’Andrea
I whakaputaina 2018Revisão -
4
Molecular Biology of Fanconi Anemia: Implications for Diagnosis and Therapy mā Alan D. D’Andrea, Markus Grompe
I whakaputaina 1997Artigo -
5
Molecular pathogenesis of Fanconi anemia: recent progress mā Toshiyasu Taniguchi, Alan D. D’Andrea
I whakaputaina 2006Revisão -
6
Molecular pathogenesis and clinical management of Fanconi anemia mā Younghoon Kee, Alan D. D’Andrea
I whakaputaina 2012Revisão -
7
-
8
Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway mā Hyungjin Kim, Alan D. D’Andrea
I whakaputaina 2012Revisão -
9
REV7 directs DNA repair pathway choice mā Connor S. Clairmont, Alan D. D’Andrea
I whakaputaina 2021Revisão -
10
Chromatin Remodeling at DNA Double-Strand Breaks mā Brendan D. Price, Alan D. D’Andrea
I whakaputaina 2013Revisão -
11
-
12
Erythropoietin receptor. Subunit structure and activation. mā Alan D. D’Andrea, L I Zon
I whakaputaina 1990Revisão -
13
-
14
-
15
The Fanconi Anemia/BRCA pathway: new faces in the crowd mā Richard D. Kennedy, Alan D. D’Andrea
I whakaputaina 2005Revisão -
16
How the Fanconi Anemia Pathway Guards the Genome mā George‐Lucian Moldovan, Alan D. D’Andrea
I whakaputaina 2009Revisão -
17
-
18
Repair Pathway Choices and Consequences at the Double-Strand Break mā Raphaël Ceccaldi, Beatrice Rondinelli, Alan D. D’Andrea
I whakaputaina 2015Revisão -
19
-
20
The Fanconi Anemia Pathway in Cancer mā Niraj Joshi, Anniina Färkkilä, Alan D. D’Andrea
I whakaputaina 2018Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Genetics
Gene
DNA repair
DNA
Cancer research
Cell biology
Fanconi anemia
Molecular biology
DNA damage
Biochemistry
Cancer
FANCD2
Medicine
Internal medicine
Homologous recombination
Genome instability
Mutation
Immunology
Polymerase
Poly ADP ribose polymerase
Ubiquitin
Oncology
Ovarian cancer
PARP inhibitor
DNA replication
Cell cycle
Chemistry
Stem cell
Germline mutation